3D printing (3DP) is forecast to be a highly revolutionary technology within the pharmaceutical sector. In particular, the main benefits of 3DP lie in the production of small batches of medicines, each with tailored dosages, shapes, sizes and release characteristics. The manufacture of medicines in this way may finally lead to the concept of personalised medicines becoming a reality. In the shorter term, 3DP could be extended throughout the drug development process, ranging from preclinical development and clinical trials, through to frontline medical care. In this review, we provide a timely perspective on the motivations and potential applications of 3DP pharmaceuticals, as well as a practical viewpoint on how 3DP could be integrated across the pharmaceutical space.
3D Printing Pharmaceuticals: Drug Development to Frontline Care.
Sarah J Trenfield,Atheer Awad,A. Goyanes,S. Gaisford,A. Basit
Published 2018 in TIPS - Trends in Pharmacological Sciences
ABSTRACT
PUBLICATION RECORD
- Publication year
2018
- Venue
TIPS - Trends in Pharmacological Sciences
- Publication date
2018-05-01
- Fields of study
Medicine, Materials Science, Business, Engineering
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-73 of 73 references · Page 1 of 1